Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis-Reference-Cited by-同舟云学术

Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis

Published:1998-09 Issue:1 Volume:125 Page:29-34
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Berry C N,Lunven C,Lechaire I,Girardot C,O'Connor S E

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0702030/fullpdf

Reference33 articles.

1. Rebound increase of Pai-1 following local intra-arterial rt-Pa infusion, a possible cause of reocclusion;Åstedt;Blood Coagulation and Fibrinolysis,1993

2. Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive centre loop;Audenaert;J. Biol. Chem.,1994

3. Effects of Xr5118 on Pai-1 and tpa activity and arterial thrombus formation in the anaesthetised rat;Barnes;Brit. J. Pharmacol.,1996

4. Antithrombotic actions of argatroban in rat models of venous ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding time;Berry;Br. J. Pharmacol.,1994

5. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen-activator inhibitor type 1-neutralizing antibody;Biemond;Circulation,1995

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke;Blood;2015-02-19

2. Evaluation of Antithrombotic Activity of Thrombin DNA Aptamers by a Murine Thrombosis Model;PLoS ONE;2014-09-05

3. Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1;Thrombosis Research;2012-04

4. S35972, a direct-acting thrombin inhibitor with high oral bioavailability and antithrombotic efficacy;Journal of Thrombosis and Haemostasis;2011-07

5. Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivo;Thrombosis Research;2011-07